Summit Partners Public Asset Management »

Intra Cellular Therapies shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $5.4M 85k 63.32
2023-03-31 $2.7M 51k 54.15
2022-06-30 $7.9M 138k 57.08
2022-03-31 $15M 240k 61.19

More positions owned by Summit Partners Public Asset Management

Spotify Technology S A SHS (SPOT)
Insmed Com Par $.01 Call Option (INSM)
Verona Pharma Sponsored Ads (VRNA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Ge Vernova (GEV)
Microsoft Corporation (MSFT)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A Put Option (SEI)
Mongodb Cl A Put Option (MDB)
Rubrik Cl A (RBRK)
Genedx Holdings Corp Com Cl A (WGS)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
MKS Instruments Call Option (MKSI)
Astera Labs (ALAB)

View all positions for Summit Partners Public Asset Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies